| |
| |
|
| Insider
Information: |
Obrien Patrick |
| Relationship: |
COO and General Counsel |
| City: |
Pasadena |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
464,385 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$10,272,196 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
464,385 |
|
|
| Total
Value |
$10,272,196 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -25.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Arrowhead Pharmaceuticals Inc |
ARWR |
COO and General Counsel |
2024-01-05 |
464,385 |
2014-12-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARWR |
Arrowhead Pharmaceuticals... |
COO and General Counsel |
• – – |
2024-01-05 |
4 |
AS |
$33.99 |
$805,716 |
D/D |
(22,841) |
464,385 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
COO and General Counsel |
• – – |
2024-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
85,000 |
487,226 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
COO and General Counsel |
• – – |
2024-01-04 |
4 |
AS |
$32.63 |
$52,208 |
D/D |
(1,600) |
402,226 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
COO and General Counsel |
• – – |
2024-01-03 |
4 |
AS |
$31.83 |
$282,439 |
D/D |
(8,749) |
403,826 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
COO and General Counsel |
• – – |
2023-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
428,375 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
COO and General Counsel |
• – – |
2023-01-03 |
4 |
AS |
$37.53 |
$670,802 |
D/D |
(17,500) |
363,375 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
General Counsel |
• – – |
2022-12-21 |
4 |
OE |
$6.15 |
$196,800 |
D/D |
32,000 |
380,875 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
General Counsel |
• – – |
2022-01-05 |
4 |
AS |
$60.49 |
$2,005,875 |
D/D |
(32,500) |
348,875 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
General Counsel |
• – – |
2022-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
381,375 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
General Counsel |
• – – |
2021-12-31 |
4 |
OE |
$6.15 |
$172,200 |
D/D |
28,000 |
321,375 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
General Counsel |
• – – |
2021-02-08 |
4 |
S |
$86.72 |
$7,961,240 |
D/D |
(90,000) |
293,375 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
General Counsel |
• – – |
2021-02-08 |
4 |
OE |
$5.22 |
$469,800 |
D/D |
90,000 |
383,375 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
General Counsel |
• – – |
2021-01-06 |
4 |
AS |
$70.78 |
$1,810,346 |
D/D |
(25,000) |
293,375 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
General Counsel |
• – – |
2021-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
318,375 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
General Counsel |
• – – |
2020-12-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
800 |
348,075 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
General Counsel |
• – – |
2020-01-06 |
4 |
AS |
$59.61 |
$879,261 |
D/D |
(14,625) |
258,375 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
General Counsel |
• – – |
2020-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
70,000 |
273,000 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
General Counsel |
• – – |
2019-05-28 |
4 |
S |
$24.88 |
$746,400 |
D/D |
(30,000) |
203,000 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
General Counsel |
• – – |
2019-01-18 |
4 |
AS |
$14.43 |
$1,038,960 |
D/D |
(72,000) |
233,000 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
General Counsel |
• – – |
2019-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
70,000 |
305,000 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
General Counsel |
• – – |
2018-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
235,000 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
General Counsel |
• – – |
2017-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
145,000 |
175,000 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
General Counsel |
• – – |
2014-12-02 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
0 |
- |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
